Credit Suisse’s PetMed Express PETS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-31,007
| Closed | -$318K | – | 3124 |
|
|
2023
Q3 | $318K | Sell |
31,007
-2,294
| -7% | -$28.3K | ﹤0.01% | 2910 |
|
|
2023
Q2 | $459K | Buy |
33,301
+5,677
| +21% | +$85.2K | ﹤0.01% | 2828 |
|
|
2023
Q1 | $449K | Sell |
27,624
-2,093
| -7% | -$39.4K | ﹤0.01% | 2805 |
|
|
2022
Q4 | $526K | Sell |
29,717
-2,027
| -6% | -$40.3K | ﹤0.01% | 2750 |
|
|
2022
Q3 | $619K | Sell |
31,744
-1,930
| -6% | -$41K | ﹤0.01% | 2661 |
|
|
2022
Q2 | $670K | Buy |
33,674
+2,932
| +10% | +$65.5K | ﹤0.01% | 2653 |
|
|
2022
Q1 | $794K | Buy |
30,742
+3,759
| +14% | +$97.5K | ﹤0.01% | 2684 |
|
|
2021
Q4 | $682K | Buy |
26,983
+7,946
| +42% | +$220K | ﹤0.01% | 3611 |
|
|
2021
Q3 | $512K | Sell |
19,037
-2,341
| -11% | -$67.4K | ﹤0.01% | 3784 |
|
|
2021
Q2 | $680K | Sell |
21,378
-10,230
| -32% | -$325K | ﹤0.01% | 3649 |
|
|
2021
Q1 | $1.11M | Buy |
31,608
+2,226
| +8% | +$77.4K | ﹤0.01% | 3256 |
|
|
2020
Q4 | $943K | Sell |
29,382
-2,335
| -7% | -$72K | ﹤0.01% | 3383 |
|
|
2020
Q3 | $1M | Sell |
31,717
-11,203
| -26% | -$371K | ﹤0.01% | 2935 |
|
|
2020
Q2 | $1.53M | Buy |
42,920
+4,391
| +11% | +$152K | ﹤0.01% | 2595 |
|
|
2020
Q1 | $1.11M | Buy |
38,529
+9,512
| +33% | +$249K | ﹤0.01% | 2579 |
|
|
2019
Q4 | $683K | Sell |
29,017
-6,529
| -18% | -$146K | ﹤0.01% | 3383 |
|
|
2019
Q3 | $640K | Buy |
35,546
+1,100
| +3% | +$18.2K | ﹤0.01% | 3291 |
|
|
2019
Q2 | $540K | Buy |
34,446
+1,809
| +6% | +$35.6K | ﹤0.01% | 3356 |
|
|
2019
Q1 | $744K | Sell |
32,637
-9,273
| -22% | -$209K | ﹤0.01% | 3111 |
|
|
2018
Q4 | $974K | Buy |
41,910
+22,131
| +112% | +$591K | ﹤0.01% | 2792 |
|
|
2018
Q3 | $652K | Sell |
19,779
-76,683
| -79% | -$2.87M | ﹤0.01% | 3141 |
|
|
2018
Q2 | $4.25M | Sell |
96,462
-17,047
| -15% | -$660K | ﹤0.01% | 1844 |
|
|
2018
Q1 | $4.74M | Buy |
113,509
+36
| +0% | +$1.66K | ﹤0.01% | 1745 |
|
|
2017
Q4 | $5.16M | Buy |
113,473
+7,493
| +7% | +$295K | ﹤0.01% | 1760 |
|
|
2017
Q3 | $3.51M | Buy |
105,980
+53,928
| +104% | +$2.2M | ﹤0.01% | 2060 |
|
|
2017
Q2 | $2.11M | Sell |
52,052
-29,941
| -37% | -$928K | ﹤0.01% | 2194 |
|
|
2017
Q1 | $1.65M | Sell |
81,993
-837
| -1% | -$17.7K | ﹤0.01% | 2495 |
|
|
2016
Q4 | $1.91M | Buy |
82,830
+16,831
| +26% | +$361K | ﹤0.01% | 2474 |
|
|
2016
Q3 | $1.34M | Sell |
65,999
-16,015
| -20% | -$323K | ﹤0.01% | 2706 |
|
|
2016
Q2 | $1.54M | Buy |
82,014
+51,811
| +172% | +$952K | ﹤0.01% | 2549 |
|
|
2016
Q1 | $541K | Buy |
30,203
+761
| +3% | +$13K | ﹤0.01% | 3193 |
|
|
2015
Q4 | $504K | Buy |
29,442
+8,827
| +43% | +$148K | ﹤0.01% | 3374 |
|
|
2015
Q3 | $331K | Sell |
20,615
-8,407
| -29% | -$141K | ﹤0.01% | 3659 |
|
|
2015
Q2 | $501K | Sell |
29,022
-1,395
| -5% | -$23.4K | ﹤0.01% | 3727 |
|
|
2015
Q1 | $503K | Sell |
30,417
-19,537
| -39% | -$303K | ﹤0.01% | 3540 |
|
|
2014
Q4 | $718K | Sell |
49,954
-1,172
| -2% | -$15.8K | ﹤0.01% | 3425 |
|
|
2014
Q3 | $695K | Buy |
51,126
+16,202
| +46% | +$226K | ﹤0.01% | 3373 |
|
|
2014
Q2 | $471K | Sell |
34,924
-18,655
| -35% | -$246K | ﹤0.01% | 3865 |
|
|
2014
Q1 | $719K | Sell |
53,579
-4,248
| -7% | -$58.9K | ﹤0.01% | 3421 |
|
|
2013
Q4 | $962K | Sell |
57,827
-29,012
| -33% | -$453K | ﹤0.01% | 3311 |
|
|
2013
Q3 | $1.41M | Buy |
86,839
+44,156
| +103% | +$689K | ﹤0.01% | 2679 |
|
|
2013
Q2 | $538K | Buy |
+42,683
| New | +$556K | ﹤0.01% | 3255 |
|
Other funds holding PETS
Credit Suisse's PETS Position: Q4 2023 in Review
Credit Suisse sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 31,007 shares — an estimated $318K sold.
Credit Suisse first reported a position in PETS in Q2 2013 and held it in 42 quarters. The position peaked at $5.16M in Q4 2017. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.
- Credit Suisse reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
- Credit Suisse sold 31,007 PetMed Express shares in Q4 2023, an estimated $318K.
- Credit Suisse first reported a position in PetMed Express in Q2 2013 and held it in 42 quarters.
- Credit Suisse's PetMed Express position peaked at $5.16M in Q4 2017.
- 130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.
Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.